Clinical Trials Logo

Headache clinical trials

View clinical trials related to Headache.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06112587 Active, not recruiting - Migraine Clinical Trials

Muscle Function and Strength Training of the Neck and Shoulder in Migraine and Tension-type Headache Patients. A Singel Arm Open Label Trial

MUST-MITH
Start date: October 6, 2023
Phase: N/A
Study type: Interventional

A Single-Arm Open-Label Trial was performed at the Danish Headache Center (DHC), Department of Neurology, Rigshospitalet - Glostrup as part of the clinic. Purpose: To examine the effects of supervised group strength training and posture correction on headache frequency and muscle function around the neck and shoulders in patients with migraine and tension-type headaches. Hypothesis: Strength training of the neck and shoulders results in improved muscle function, which leads to a reduction in headache.

NCT ID: NCT06109389 Active, not recruiting - Clinical trials for Chronic Migraine, Headache

The Efficacy Of Lidocaine Infusion IN Chronic Unilateral Migraine Headache

Start date: October 1, 2023
Phase: Phase 2
Study type: Interventional

STUDY THE EFFICACY OF INTRAVENOUS LIDOCAINE INFUSION ON PATIENTS WITH CHRONICUNILATERAL MIGRAINE HEADACHE ..NO OF PATIENTS 80..WILLBE DIVIDED INTO 2 GROUPS..FIRST WILL RECEIVE MEDICAL TREATMENT PLUS LIDOCAINE INFUSION ONCE WEEKLY FOR 4 SUCCESIVE WEEKS ,OTHER WILL RECEIVE MEDICAL TREATMENT PLUS SALINE INFUSION SAME REGIMNE,FOLLOW UP USING MONTHLY MIGRAINE DAYS,VAS SCORE,MIDAS SCORE,QUALITY OF LIFE QUESTIONAIRE,PRE AND POST MEASUREMENT OF CALCITONIN GENE RELATED PEPTIDE

NCT ID: NCT06011811 Active, not recruiting - Cluster Headache Clinical Trials

Cluster Headache Treatment Survey

Start date: June 29, 2023
Phase:
Study type: Observational

The objective of this study is to survey patients with cluster headache about treatment effectiveness and their views on treatments. Participants will complete one brief questionnaire online.

NCT ID: NCT06004388 Active, not recruiting - Migraine Clinical Trials

Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C)

Start date: July 21, 2023
Phase: Phase 3
Study type: Interventional

Randomized study of two digital therapeutics for the prevention of episodic migraine in patients currently receiving Calcitonin Gene-Related Peptide (CGRP) Inhibitor Therapy

NCT ID: NCT05984719 Active, not recruiting - Clinical trials for New Daily Persistent Headache

New Daily Persistent Headache Survey

NDPH
Start date: June 19, 2023
Phase:
Study type: Observational

Purpose: to explore headache characteristics and treatment effects of patient with new daily persistent headache (NDPH) through an online survey. Research design: Online survey of patients with new daily persistent headache. Risks: Risks include a breach of confidentiality as well as fatigue from taking the survey online. Importance of knowledge that may recently be expected to result: The study aims to discover new information in a very understudied disease. This information could, in future studies, help change the diagnostic criteria or lead to new treatment options.

NCT ID: NCT05888298 Active, not recruiting - Migraine Disorders Clinical Trials

Proximal and Distal Approach GON RFT in Migraine

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Greater occipital nerve pulsed radiofrequency therapy is used in the treatment of migraine. This method is applied at the level of the proximal c2 vertebra and by approaching the nerve from the distal 1/3 medial of the occipital protuberant. The investigators aimed to compare the effectiveness of these two methods.

NCT ID: NCT05883813 Active, not recruiting - Clinical trials for Tension-Type Headache

Immediate Effects of Suboccipital Muscle Release Combined With Sustained Natural Apophyseal Glides in Patients With Chronic Tension Type Headache

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

Headache disorder characterized by recurrent headache are among the most common disoredrs of the nervous system. Tension type headache is widely recognized kind of headache that affects 80% of the individuals. Its underlying cause has not been clearly distinguished. It is managed both pharmacology and non-pharmacology which includes dry needling, acupuncture, manual techniques and massage. Several studies conducted which showed that both the soft tissue muscle inhibition and joint mobilization techniques are effective in decreasing pain. But there is lack of evidence which shows combined effects of soft tissue muscle inhibition and sustained natural apophyseal glides(SNAGS) in chronic tension type headache. so this study will compare the effects of soft tissue muscle release and SNAGS on pain intensity and cervical range of motion.

NCT ID: NCT05777395 Active, not recruiting - Clinical trials for Cervicogenic Headache

Comparison of Maitland Oscillatory Mobilizations With Kaltenborn Sustained Stretch Mobilizations in Cervicogenic Headache Patients

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

Cervicogenic headache is a common headache that causes disability and affects everyday activities. Headache related disorders are the second most common reason for years lived with disability all over the world. According to the latest International Headache Society model, cervicogenicheadache (CGH) is a secondary headache having C1-C2 dysfunction. There is marked limitation in cervical ROM specially rotation. Treatment indicated involves use of electrotherapy and thermal modalities. In addition, use of different manual therapy techniques are advocated to eliminate the root cause i.e. C1-C2 dysfunction. Maitland mobilizations for cervical spine have been found to be effective in treating CGH patients. Maitland mobilizations uses oscillatory mobilizations and has four grades. Kaltenborn, on the other hand, applies sustained stretches and has 3 grades.So, the study will be focusing on comparing the effectiveness of these two mobilizations on cervicogenic headache patients.

NCT ID: NCT05635656 Active, not recruiting - Clinical trials for Post-Concussion Syndrome

Digital Solutions for Concussion

DiSCo
Start date: November 25, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to develop new digital solutions for patients with prolonged postconcussion symptoms, and investigate its usability, feasibility, and safety. The digital solutions consist of a 1) symptom mapping and clinical decision support system, and 2) a research-based system for home-based biofeedback treatment.

NCT ID: NCT05608642 Active, not recruiting - Clinical trials for Medication Overuse Headache

Intravenous Treatments Used in Medication Overuse Headache Bridge Treatment

Start date: October 22, 2022
Phase: N/A
Study type: Interventional

Medication overuse headache is the chronicity of headaches, which occurs more than 15 days a month, as a result of frequent use of painkillers, opioids or migraine attack drugs (ergotamine, triptan) in individuals with pre-existing primary headache disease. In the treatment of this headache, two ways can be followed as slow drug discontinuation or sudden drug discontinuation. The most commonly used method is the sudden discontinuation of the overused analgesic agent, the initiation of prophylactic treatment, and then the application of bridge therapy for 6-10 days. Intravenous hydration, steroids, antiemetics, neuroleptic drugs and local anesthetic drugs such as lidocaine can be used in bridge treatment.